In Vitro Uptake of SCH 27899 (Evernimicin) by Rat Alveolar Macrophages

AUTOR(ES)

Zbaida, Shmuel

FONTE

American Society for Microbiology

RESUMO

The in vitro uptake of [14C]evernimicin ([14C]SCH 27899) by primary cultures of rat alveolar macrophages and hepatocytes was determined. Both cell populations exhibited linear rates of uptake. However, the initial rate of drug uptake by alveolar macrophages was about threefold higher than that by hepatocytes. These findings demonstrate that [14C]evernimicin is taken up by rat alveolar macrophages, supporting the likelihood that the drug is able to reach sites of infection.

Documentos Relacionados

• Efficacy of an Evernimicin (SCH27899) In Vitro and in an Animal Model of Lyme Disease
• In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis
• In Vivo Activities of Evernimicin (SCH 27899) against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci in Experimental Endocarditis
• Evernimicin (SCH27899) Inhibits both Translation and 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells
• Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants